| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918421 | Radiotherapy and Oncology | 2014 | 7 Pages |
Abstract
HPV16 DNA status appears to be a strong prognosticator of loco-regional tumour control after postoperative cisplatin-based radiochemotherapy of locally advanced oropharyngeal carcinoma and is now being explored in a prospective validation trial.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Fabian Lohaus, Annett Linge, Inge Tinhofer, Volker Budach, Eleni Gkika, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Melanie Avlar, Anca-Ligia Grosu, Amir Abdollahi, Jürgen Debus, Christine Bayer, Claus Belka, Steffi Pigorsch,